The drug is add-on therapy for asymptomatic and symptomatic Covid patients. Khoday Group of Industries, a Bengaluru based company, has rolled out ViraNorm - ayurvedic immuno-modulator, which helps treat Covid-19 patients. Through the launch of ‘ViraNorm’, Khoday Group is entering the alternative medicine sector.
The drug ‘ViraNorm’ has been developed by Khoday Group in collaboration with Athera Dabur Research Foundation (DRF) LifeSciences.
According to the company, ‘ViraNorm’ has undergone Phase 3 clinical trials in the country for an ayurvedic formulation and conducted according to international standards of good clinical trials and is found to be effective in clinical trials and has been launched after subjecting it, thorough efficacy and safety studies. It helps to halt the progression of viruses in the body. So, this can be referred as an add-on therapy/medication for asymptomatic and symptomatic Covid patients. This helps in stopping the migration of the patie